Home » Topics » BioWorld

BioWorld
RSS

APPLIED BIOSCIENCE TO SELL SHARES

May 6, 1992

PROLEUKIN SHIPMENTS TO BEGIN

May 6, 1992

UBS MARKETING DEAL WITH SMITHKLINE

May 6, 1992

IMMUNOMEDICS LOSES EUROPEAN PATENT

May 6, 1992

LIPO DRUG SHOWS PROMISE IN ANIMALS

May 5, 1992

FREEZE-DRIED BLOOD SUCCESSFULLY RECYCLED

May 5, 1992

CYGNUS CLOSES PROPOSED OFFERING

May 5, 1992

VESTAR ACQUIRES LIPID TECHNOLOGY RIGHTS

May 5, 1992

STOCK REBOUND CONTINUES

May 5, 1992

ALEX. BROWN CONFERENCE HIGHLIGHTS

May 5, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...